US Stock MarketDetailed Quotes

NVCT Nuvectis Pharma

Watchlist
  • 4.520
  • -0.170-3.62%
Close Dec 20 16:00 ET
  • 4.600
  • +0.080+1.77%
Post 18:06 ET
87.33MMarket Cap-3.90P/E (TTM)

Nuvectis Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-29.21%4.36M
-19.56%4.64M
7.19%4.4M
19.04%22.9M
1.30%6.87M
3.70%6.16M
61.54%5.77M
39.25%4.1M
49.17%19.23M
199.25%6.78M
Selling and administrative expenses
-7.89%1.54M
12.58%1.7M
0.12%1.74M
25.14%7.52M
9.24%2.6M
17.91%1.67M
41.39%1.51M
52.11%1.73M
79.37%6.01M
112.40%2.38M
-General and administrative expense
-7.89%1.54M
12.58%1.7M
0.12%1.74M
25.14%7.52M
9.24%2.6M
17.91%1.67M
41.39%1.51M
52.11%1.73M
79.37%6.01M
112.40%2.38M
Research and development costs
-37.16%2.82M
-30.95%2.94M
12.38%2.66M
16.28%15.38M
-3.00%4.27M
-0.75%4.49M
70.14%4.26M
31.14%2.37M
38.58%13.23M
284.35%4.4M
Operating profit
29.21%-4.36M
19.56%-4.64M
-7.19%-4.4M
-19.04%-22.9M
-1.30%-6.87M
-3.70%-6.16M
-61.54%-5.77M
-39.25%-4.1M
-49.17%-19.23M
-199.25%-6.78M
Net non-operating interest income expense
-25.63%206K
235.94%215K
332.69%225K
327.52%637K
197.56%244K
354.10%277K
1,500.00%64K
2,500.00%52K
3,625.00%149K
1,950.00%82K
Non-operating interest income
-25.63%206K
235.94%215K
332.69%225K
327.52%637K
197.56%244K
354.10%277K
1,500.00%64K
2,500.00%52K
3,625.00%149K
1,950.00%82K
Other net income (expense)
Income before tax
29.38%-4.15M
22.42%-4.43M
-3.01%-4.17M
-16.64%-22.26M
1.11%-6.62M
-0.07%-5.88M
-59.93%-5.71M
-37.58%-4.05M
-48.06%-19.09M
-196.15%-6.7M
Income tax
Net income
29.38%-4.15M
22.42%-4.43M
-3.01%-4.17M
-16.64%-22.26M
1.11%-6.62M
-0.07%-5.88M
-59.93%-5.71M
-37.58%-4.05M
-48.06%-19.09M
-196.15%-6.7M
Net income continuous Operations
29.38%-4.15M
22.42%-4.43M
-3.01%-4.17M
-16.64%-22.26M
1.11%-6.62M
-0.07%-5.88M
-59.93%-5.71M
-37.58%-4.05M
-48.06%-19.09M
-196.15%-6.7M
Minority interest income
Net income attributable to the parent company
29.38%-4.15M
22.42%-4.43M
-3.01%-4.17M
-16.64%-22.26M
1.11%-6.62M
-0.07%-5.88M
-59.93%-5.71M
-37.58%-4.05M
-48.06%-19.09M
-196.15%-6.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
29.38%-4.15M
22.42%-4.43M
-3.01%-4.17M
-16.64%-22.26M
1.11%-6.62M
-0.07%-5.88M
-59.93%-5.71M
-37.58%-4.05M
-48.06%-19.09M
-196.15%-6.7M
Basic earnings per share
35.14%-0.24
31.58%-0.26
7.41%-0.25
5.30%-1.43
14.58%-0.41
11.90%-0.37
-35.71%-0.38
15.63%-0.27
-38.44%-1.51
-150.89%-0.48
Diluted earnings per share
35.14%-0.24
31.58%-0.26
7.41%-0.25
5.30%-1.43
14.58%-0.41
11.90%-0.37
-35.71%-0.38
15.63%-0.27
-38.44%-1.51
-150.89%-0.48
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -29.21%4.36M-19.56%4.64M7.19%4.4M19.04%22.9M1.30%6.87M3.70%6.16M61.54%5.77M39.25%4.1M49.17%19.23M199.25%6.78M
Selling and administrative expenses -7.89%1.54M12.58%1.7M0.12%1.74M25.14%7.52M9.24%2.6M17.91%1.67M41.39%1.51M52.11%1.73M79.37%6.01M112.40%2.38M
-General and administrative expense -7.89%1.54M12.58%1.7M0.12%1.74M25.14%7.52M9.24%2.6M17.91%1.67M41.39%1.51M52.11%1.73M79.37%6.01M112.40%2.38M
Research and development costs -37.16%2.82M-30.95%2.94M12.38%2.66M16.28%15.38M-3.00%4.27M-0.75%4.49M70.14%4.26M31.14%2.37M38.58%13.23M284.35%4.4M
Operating profit 29.21%-4.36M19.56%-4.64M-7.19%-4.4M-19.04%-22.9M-1.30%-6.87M-3.70%-6.16M-61.54%-5.77M-39.25%-4.1M-49.17%-19.23M-199.25%-6.78M
Net non-operating interest income expense -25.63%206K235.94%215K332.69%225K327.52%637K197.56%244K354.10%277K1,500.00%64K2,500.00%52K3,625.00%149K1,950.00%82K
Non-operating interest income -25.63%206K235.94%215K332.69%225K327.52%637K197.56%244K354.10%277K1,500.00%64K2,500.00%52K3,625.00%149K1,950.00%82K
Other net income (expense)
Income before tax 29.38%-4.15M22.42%-4.43M-3.01%-4.17M-16.64%-22.26M1.11%-6.62M-0.07%-5.88M-59.93%-5.71M-37.58%-4.05M-48.06%-19.09M-196.15%-6.7M
Income tax
Net income 29.38%-4.15M22.42%-4.43M-3.01%-4.17M-16.64%-22.26M1.11%-6.62M-0.07%-5.88M-59.93%-5.71M-37.58%-4.05M-48.06%-19.09M-196.15%-6.7M
Net income continuous Operations 29.38%-4.15M22.42%-4.43M-3.01%-4.17M-16.64%-22.26M1.11%-6.62M-0.07%-5.88M-59.93%-5.71M-37.58%-4.05M-48.06%-19.09M-196.15%-6.7M
Minority interest income
Net income attributable to the parent company 29.38%-4.15M22.42%-4.43M-3.01%-4.17M-16.64%-22.26M1.11%-6.62M-0.07%-5.88M-59.93%-5.71M-37.58%-4.05M-48.06%-19.09M-196.15%-6.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 29.38%-4.15M22.42%-4.43M-3.01%-4.17M-16.64%-22.26M1.11%-6.62M-0.07%-5.88M-59.93%-5.71M-37.58%-4.05M-48.06%-19.09M-196.15%-6.7M
Basic earnings per share 35.14%-0.2431.58%-0.267.41%-0.255.30%-1.4314.58%-0.4111.90%-0.37-35.71%-0.3815.63%-0.27-38.44%-1.51-150.89%-0.48
Diluted earnings per share 35.14%-0.2431.58%-0.267.41%-0.255.30%-1.4314.58%-0.4111.90%-0.37-35.71%-0.3815.63%-0.27-38.44%-1.51-150.89%-0.48
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data